Morbi et tellus imperdiet, aliquam nulla sed, dapibus erat. Aenean dapibus sem non purus venenatis vulputate. Donec accumsan eleifend blandit. Nullam auctor ligula

Get In Touch

Quick Email
info.help@gmail.com
  • Home |
  • Astellas axes early Sjögren’s trial in latest setback for autoimmune disease community

Astellas axes early Sjögren’s trial in latest setback for autoimmune disease community

  • March 30, 2026

Astellas Pharma has become the latest company to pull back from a potential treatment for Sjögren’s syndrome, an autoimmune disease that still lacks any dedicated medicines.

Leave A Comment

Fields (*) Mark are Required